NESS ZIONA, Israel, May 31, 2013 /PRNewswire/ --
NeuroDerm, Ltd. announced today that Oded Lieberman, PhD MBA, the company's Chief Executive Officer, will present at the Jefferies 2013 Global Healthcare Conference in New York on Monday, June 3, 2013 at 8:00 a.m. EDT. The conference will be held at the Grand Hyatt in New York, NY.
NeuroDerm is an emerging pharmaceutical company that develops therapies for the treatment of CNS diseases. NeuroDerm's technology is based on proprietary reformulations of well-established oral drugs that achieve better efficacy. The company's lead products are ND0611 and ND0612, novel sub-cutaneous drug formulations for the treatment of Parkinson's disease, and ND0801, a combination drug for the treatment of cognitive disorders in diseases such as ADD/ADHD, schizophrenia and Alzheimer's disease. NeuroDerm is headquartered in the Weizmann Science Park, Ness Ziona, Israel.
Oded S. Lieberman, PhD MBA, Chairman & CEO
SOURCE NeuroDerm Ltd